Benign Prostatic Hyperplasia
Conditions
Interventions
Sponsors
Beijing Friendship Hospital, Capital Medical University
Eligibility
Sex/Gender
Male
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Males aged 40–85 years; 2I.PSS>12, Qmax 150 mL); 3.Prostate volume > 80 mL confirmed by ultrasound/MRI; 4.Diagnosed with BPH presenting with lower urinary tract symptoms and scheduled for transurethral prostate laser surgery; 5.Voluntarily participate in the clinical trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients complicated with bladder stones; 2.Subjects with urethral stricture causing difficulty in instrument insertion; 3.Neurogenic lower urinary tract symptoms; 4.Prostate-specific antigen (PSA) levels outside the normal range with inability to rule out prostate cancer; 5.Bladder cancer or other malignant tumors of the urinary system; 6.Patients who have previously undergone BPH or urethral surgery; 7.Severe cardiovascular, pulmonary, or other systemic diseases rendering the patient unable to tolerate surgery; 8.Participation in other clinical trials within three months prior to enrollment; 9.Subjects deemed unsuitable for this clinical trial by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score,QoL;Maximum urinary flow rate (Qmax);Postvoid Residual Urine,PVR;Voided Volume,VV;Operation time, postoperative irrigation time, catheter indwelling time, postoperative hospital stay;Evaluation index of sexual function(IIEF-5, MSHQ-EjD);Overactive Bladder Index (OABSS);Hemoglobin change, transfusion rate;Changes of serum sodium ion;Complications;Quality of surgical recovery score (QoR VAS) at 1 month after surgery; | — |
Countries
China
Contacts
Public ContactNiu Yinong
Beijing Friendship Hospital, Capital Medical University
Outcome results
None listed